Insys therapeutics, inc. (INSY)
CashFlow / Quarterly
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Cash flows from operating activities:
Net loss

-123,844

-46,293

-30,494

-27,350

-20,370

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-6,524

-

2,925

6,027

2,290

18,142

24,631

9,413

5,867

7,426

11,505

9,465

7,658

24,100

11,587

4,547

143

-7,073

-4,250

-6,368

-6,687

Adjustments to reconcile net loss to net cash used in operating activities:
Inventory obsolescence reserve

2,831

1,597

493

477

528

-145

3,372

854

2,105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

1,961

1,890

1,938

1,813

1,938

1,832

1,817

1,914

1,774

1,715

1,511

1,496

1,527

1,466

1,368

1,282

1,175

789

604

584

523

477

446

436

429

443

375

411

433

Stock-based compensation

3,109

2,599

2,863

3,384

3,170

2,967

4,768

4,288

3,992

4,118

8,399

4,946

4,126

9,615

4,320

4,227

3,720

4,065

3,037

5,731

2,456

2,238

1,697

1,345

1,059

904

571

639

647

Deferred income tax benefit

-

-

-

-

-

-30,927

4,376

-1,157

4,465

-858

4,151

1,758

585

2,342

700

930

942

-38

-929

1,470

152

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-851

-332

0

0

-108

-

-

-

-

-

-

-

-

0

0

0

-41

-

-

-

-

-

-

-

-

-

-

-

-

Impairment on property and equipment

129

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of notes receivable and other assets due from stockholders

-

0

0

0

26

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash operating lease expense

34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits on stock options and awards

-

-

-

-

-

-

-

-

-

-

-259

281

653

-

1,446

3,810

3,601

1,960

7,090

7,217

5,182

-

-

-

-

-

-

-

-

Amortization of investment discount

-58

-81

-7

21

93

183

266

329

347

437

469

554

569

573

379

285

194

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense accrued on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

262

638

-

-

-

-

Changes in operating assets and liabilities:
Interest expense accrued on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

633

Accretion (re-valuation) of contingent payment obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,324

70

70

70

Accounts receivable, net

-6,523

-107

-7,350

4,556

-6,002

-1,736

-723

10,659

-7,341

-12,907

-5,838

18,736

-26,609

16,835

-4,135

2,955

8,115

-3,550

11,972

-3,366

2,740

3,937

3,246

3,314

2,727

3,110

-3,534

1,206

2,307

Inventories

-195

-1,507

177

105

-1,035

-2,334

428

-792

447

-4,638

-1,292

-3,382

1,665

2,005

-121

317

1,079

6,658

6,735

5,300

4,878

2,782

3,068

500

1,083

-1,051

508

-437

1,340

Prepaid expenses and other current assets

-1,633

-11,768

217

1,726

361

3,663

4,934

4,568

1,353

1,059

-1,421

1,979

104

-1,869

-111

421

214

2,031

-375

1,364

-53

270

437

-21

-321

47

402

-221

-155

Accounts payable, accrued expenses and other current and noncurrent liabilities

15,968

4,069

17,008

1,260

-6,535

2,840

14,032

-951

-16,039

461

5,278

1,791

-19,939

21,831

10,333

6,738

11,806

11,218

21,943

10,626

9,026

9,133

3,875

-741

2,150

-1,906

434

513

1,125

Accrued sales allowances

1,005

-

-

-

3,777

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued litigation award and settlements

-75,082

-16,337

69

1,140

-740

-34

-135,983

-4,450

3,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-16,669

-

25,847

-3,920

12,175

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued litigation award and settlements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-789

2,212

8,000

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-16,659

-7,307

-8,621

-22,658

-17,403

-

-

-

-

-

-

-

-

-

-

15,724

16,852

-

12,596

14,421

6,764

10,409

10,854

2,056

930

-2,187

469

-4,638

-7,271

Cash flows from investing activities:
Purchases of investments

6,005

11,138

14,699

10,495

25,394

23,565

36,443

25,550

46,510

29,893

43,250

19,658

22,574

54,434

36,686

36,881

10,469

14,485

12,956

12,318

16,846

-

-

-

-

-

-

-

-

Proceeds from sales of investments

-

-

-

-

6,880

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of investments

-

-

-

-

-

-

19,384

1,299

1,620

-

2,822

2,216

2,108

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of investments

27,622

26,005

30,043

25,721

22,703

22,497

28,529

20,877

26,545

20,038

40,575

18,789

16,607

10,322

13,708

8,568

4,045

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

15

2,121

2,084

1,130

760

3,063

4,585

7,104

1,909

3,265

2,848

1,878

2,623

3,099

2,637

2,915

5,191

6,558

7,273

5,399

3,015

2,338

557

2,125

105

263

310

119

328

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-20,254

-

-2,701

-531

-6,482

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

21,602

17,638

13,260

19,071

3,429

-

-

-

-

-

-

-

-

-

-

-20,033

-11,615

-

-20,229

-17,317

-19,861

-1,938

-1,357

-2,125

-105

-263

-310

-119

-328

Cash flows from financing activities:
Net repayments on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-11,358

-500

1,350

191

5,643

4,674

Proceeds from notes payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,987

Excess tax benefits on stock options and awards

-

-

-

-

-

-

-

-

-

-

-259

281

653

-

1,446

3,810

3,601

1,960

7,090

7,217

5,182

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

18

64

116

392

524

995

1,219

1,677

654

328

1,352

813

1,310

2,162

1,251

2,981

3,130

3,899

1,814

700

2,543

1,968

103

31

0

143

0

0

9

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-1

0

2,749

13,351

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

654

-

1,093

-79

-11,388

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

18

376

116

1,128

524

-

-

-

-

-

-

-

-

-

-

8,270

6,731

-

8,904

9,025

7,725

5,565

103

21,129

-500

1,493

191

5,643

7,670

Change in cash and cash equivalents

4,961

10,707

4,755

-2,459

-13,450

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in cash and cash equivalents

-

-

-

-

-

-

-

-

-36,269

-

24,239

-4,530

-5,695

-14,465

19,945

3,961

11,968

10,696

1,271

6,129

-5,372

14,036

9,600

21,060

325

-957

350

886

71

Supplemental cash flow disclosures:
Cash paid (refunded) for income taxes, net

-66

-13,385

0

-50

43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

14

-

-

-

-

8,996

3,005

3,350

0

785

-9

2,199

0

991

0

0

0

-

-

-

-

Non-cash capital expenditures

9

-993

142

285

889

12

2,024

-2,060

2,702

354

1

-70

140

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-